Dynamic change of anti‐inflammatory cytokine IL‐35 in allergen immune therapy for Japanese cedar pollinosis

Abstract

1. Klose CS, Artis D. Innate lymphoid cells as regulators of immunity, in‐ flammation and tissue homeostasis. Nat Immunol. 2016;17(7):765‐774. 2. Stier MT, Peebles RS Jr. Innate lymphoid cells and allergic disease. Ann Allergy Asthma Immunol. 2017;119(6):480‐488. 3. Yu QN, Guo YB, Li X, et al. ILC2 frequency and activity are inhib‐ ited by glucocorticoid treatment via STAT pathway in patients with asthma. Allergy. 2018;73(9):1860‐1870. 4. Zhong H, Fan X‐L, Yu Q‐N, et al. Increased innate type 2 immune re‐ sponse in house dust mite‐allergic patients with allergic rhinitis. Clin Immunol. 2017;183:293‐299. 5. Doherty TA, Khorram N, Lund S, Mehta AK, Croft M, Broide DH. Lung type 2 innate lymphoid cells express cysteinyl leukotriene re‐ ceptor 1, which regulates TH2 cytokine production. J Allergy Clin Immunol. 2013;132(1):205‐213. 6. Salimi M, Stoger L, Liu W, et al. Cysteinyl leukotriene E4 activates human group 2 innate lymphoid cells and enhances the effect of prostaglandin D2 and epithelial cytokines. J Allergy Clin Immunol. 2017;140(4):1090‐1100. 7. Matsumoto K, Kouzaki H, Yamamoto S, et al. In vitro and in vivo inhib‐ itory effects of TLR4 agonist, glucopyranosyl lipid A (GLA), on allergic rhinitis caused by Japanese cedar pollen. Allergy. 2019. https ://doi. org/10.1111/all.13989 . [Epub ahead of print] 8. Paruchuri S, Tashimo H, Feng C, et al. Leukotriene E4‐induced pul‐ monary inflammation is mediated by the P2Y12 receptor. J Exp Med. 2009;206(11):2543‐2555. 9. Peters‐Golden M, Henderson WR Jr. Leukotrienes. N Engl J Med. 2007;357(18):1841‐1854.